Search Results - "Cafro, Anna"

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma by Palumbo, Antonio, Cavallo, Federica, Gay, Francesca, Di Raimondo, Francesco, Ben Yehuda, Dina, Petrucci, Maria Teresa, Pezzatti, Sara, Caravita, Tommaso, Cerrato, Chiara, Ribakovsky, Elena, Genuardi, Mariella, Cafro, Anna, Marcatti, Magda, Catalano, Lucio, Offidani, Massimo, Carella, Angelo Michele, Zamagni, Elena, Patriarca, Francesca, Musto, Pellegrino, Evangelista, Andrea, Ciccone, Giovannino, Omedé, Paola, Crippa, Claudia, Corradini, Paolo, Nagler, Arnon, Boccadoro, Mario, Cavo, Michele

“…In patients 65 or younger with multiple myeloma, high-dose consolidation therapy was associated with longer survival and more myelotoxicity than…”
Get full text

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide by Larocca, Alessandra, Cavallo, Federica, Bringhen, Sara, Di Raimondo, Francesco, Falanga, Anna, Evangelista, Andrea, Cavalli, Maide, Stanevsky, Anfisa, Corradini, Paolo, Pezzatti, Sara, Patriarca, Francesca, Cavo, Michele, Peccatori, Jacopo, Catalano, Lucio, Carella, Angelo Michele, Cafro, Anna Maria, Siniscalchi, Agostina, Crippa, Claudia, Petrucci, Maria Teresa, Yehuda, Dina Ben, Beggiato, Eloise, Di Toritto, Tommaso Caravita, Boccadoro, Mario, Nagler, Arnon, Palumbo, Antonio

“…Lenalidomide plus dexamethasone is effective in the treatment of multiple myeloma (MM) but is associated with an increased risk of venous thromboembolism…”
Get full text

Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis by Mangiacavalli, Silvia, Cartia, Claudio Salvatore, Galli, Monica, Pezzatti, Sara, Belotti, Angelo, Fazio, Francesca, Mina, Roberto, Marcatti, Magda, Cafro, Anna, Zambello, Renato, Paris, Laura, Barilà, Gregorio, Olivares, Cecilia, Pompa, Alessandra, Mazza, Rita, Farina, Francesca, Soldarini, Martina, Benvenuti, Pietro, Pagani, Giuseppina, Palumbo, Michele, Masoni, Valeria, Ferretti, Virginia Valeria, Klersy, Catherine, Arcaini, Luca, Petrucci, Maria Teresa

“…Lenalidomide and dexamethasone (Rd)-based triplets, in particular carfilzomib-Rd (KRd) and daratumumab-Rd (DaraRd), represent a standard of care in…”
Get full text

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma by Dimopoulos, Meletios A., Palumbo, Antonio, Corradini, Paolo, Cavo, Michele, Delforge, Michel, Di Raimondo, Francesco, Weisel, Katja C., Oriol, Albert, Hansson, Markus, Vacca, Angelo, Blanchard, María Jesús, Goldschmidt, Hartmut, Doyen, Chantal, Kaiser, Martin, Petrini, Mario, Anttila, Pekka, Cafro, Anna Maria, Raymakers, Reinier, San-Miguel, Jesus, de Arriba, Felipe, Knop, Stefan, Röllig, Christoph, Ocio, Enrique M., Morgan, Gareth, Miller, Neil, Simcock, Mathew, Peluso, Teresa, Herring, Jennifer, Sternas, Lars, Zaki, Mohamed H., Moreau, Philippe

“…Patients with relapsed and/or refractory multiple myeloma (RRMM) have poor prognosis. The STRATUS study assessed safety and efficacy of pomalidomide plus…”
Get full text

Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reports by Grossi, Glenda, Viganò, Mauro, Facchetti, Floriana, Labanca, Sara, Loglio, Alessandro, Dodero, Anna, Montefusco, Vittorio, Corradini, Paolo, Cafro, Anna, Cairoli, Roberto, Colombo, Massimo, Lampertico, Pietro

Get full text

Myeloma's multiple morphologies by Cantoni, Silvia, Galitzia, Andrea, Mancini, Valentina, Cafro, Anna Maria, Cairoli, Roberto

“…Serum electrophoresis performed on admission as part of routine blood chemistry showed a monoclonal component (MC) in the gamma range which led to further…”
Get full text

A real‐world retrospective–prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience by Furlan, Anna, Cea, Michele, Pavan, Laura, Galli, Monica, Clissa, Cristina, Mangiacavalli, Silvia, Cafro, Anna Maria, Girlanda, Stefania, Patriarca, Francesca, Minotto, Claudia, Bertoldero, Giovanni, Barilà, Gregorio, Pascarella, Anna, Lico, Albana, Paolini, Rossella, Rabassi, Nicholas, Pescosta, Norbert, Porrazzo, Marika, De Sabbata, Giovanni, Pompa, Alessandra, Bega, Giulia, Cavallin, Stefania, Guidotti, Francesca, Marcatti, Magda, Rupolo, Maurizio, Belotti, Angelo, Gherlinzoni, Filippo, Zambello, Renato

“…Introduction Ixazomib, lenalidomide, and dexamethasone (IRd) have been approved for the treatment of relapsed/refractory multiple myeloma (RRMM) based on the…”
Get full text

P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL by Montefusco, Vittorio, Maria Cafro, Anna, Margiotta‐Casaluci, Gloria, Patriarca, Francesca, Mina, Roberto, D’agostino5, Mattia, Palma, Anna Benedetta Dalla, Rizzi, Rita, Genua, Angelo, Fazio, Francesca, Paris, Laura, Belotti, Angelo, Rizzello, Ilaria, Conticello, Concetta, Carlo‐Stella, Carmelo, Boccadoro, Mario

Get full text

P970: A REAL‐WORLD RETROSPECTIVE‐PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHERN ITALY EXPERIENCE by Furlan, Anna, Cea, Michele, Zambello, Renato, Pavan, Laura, Galli, Monica, Clissa, Cristina, Mangiacavalli, Silvia, Maria Cafro, Anna, Girlanda, Stefania, Patriarca, Francesca, Minotto, Claudia, Bertoldero, Giovanni, Barilà, Gregorio, Pascarella, Anna, Lico, Albana, Paolini, Rossella, Rabassi, Nicholas, Pescosta, Norbert, Porrazzo, Marika, Gherlinzoni, Filippo

Get full text

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial by Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

“…Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with multiple myeloma…”
Get full text

Impact of the Addition of Daratumumab to the Standard Bortezomib-Thalidomide-Dexamethasone Regimen on Hematopoietic Stem Cell Mobilization and Collection, Post-Transplant Engraftment and Infectious Complications: A Case-Control Multicentre Real-Life Analysis by Cavallaro, Gianluca, Galli, Monica, Paris, Laura, Stefanoni, Paola, Pavoni, Chiara, Mangiacavalli, Silvia, Masoni, Valeria, Palumbo, Michele, Pompa, Alessandra, Cafro, Anna Maria, Pezzatti, Sara, Crippa, Stefano, Rambaldi, Alessandro

“…Background The pivotal clinical trial CASSIOPEIA established the quadruplet Daratumumab-Bortezomib-Thalidomide-Dexamethasone (Dara-VTD) as superior with…”
Get full text

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study by Cavo, Michele, Gay, Francesca, Beksac, Meral, Pantani, Lucia, Petrucci, Maria Teresa, Dimopoulos, Meletios A, Dozza, Luca, van der Holt, Bronno, Zweegman, Sonja, Oliva, Stefania, van der Velden, Vincent H J, Zamagni, Elena, Palumbo, Giuseppe A, Patriarca, Francesca, Montefusco, Vittorio, Galli, Monica, Maisnar, Vladimir, Gamberi, Barbara, Hansson, Markus, Belotti, Angelo, Pour, Ludek, Ypma, Paula, Grasso, Mariella, Croockewit, Alexsandra, Ballanti, Stelvio, Offidani, Massimo, Vincelli, Iolanda D, Zambello, Renato, Liberati, Anna Marina, Andersen, Niels Frost, Broijl, Annemiek, Troia, Rossella, Pascarella, Anna, Benevolo, Giulia, Levin, Mark-David, Bos, Gerard, Ludwig, Heinz, Aquino, Sara, Morelli, Anna Maria, Wu, Ka Lung, Boersma, Rinske, Hajek, Roman, Durian, Marc, von dem Borne, Peter A, Caravita di Toritto, Tommaso, Zander, Thilo, Driessen, Christoph, Specchia, Giorgina, Waage, Anders, Gimsing, Peter, Mellqvist, Ulf-Henrik, van Marwijk Kooy, Marinus, Minnema, Monique, Mandigers, Caroline, Cafro, Anna Maria, Palmas, Angelo, Carvalho, Susanna, Spencer, Andrew, Boccadoro, Mario, Sonneveld, Pieter

“…The emergence of highly active novel agents has led some to question the role of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent…”
Get full text

Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study by Bringhen, Sara, Mina, Roberto, Cafro, Anna Maria, Liberati, Anna Marina, Spada, Stefano, Belotti, Angelo, Gaidano, Gianluca, Patriarca, Francesca, Troia, Rossella, Fanin, Renato, De Paoli, Lorenzo, Rossi, Giuseppe, Lombardo, Alessandra, Bertazzoni, Paola, Palumbo, Antonio, Sonneveld, Pieter, Boccadoro, Mario

Get full text

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD) by Bringhen, Sara, Antonioli, Elisabetta, Gamberi, Barbara, Bruno, Benedetto, Derudas, Daniele, Tosi, Patrizia, Fazio, Francesca, Mazza, Rita, Ronconi, Sonia, Corradini, Paolo, Lotti, Flavia, Cellini, Claudia, Falcone, Antonietta Pia, Galieni, Piero, Ria, Roberto, Belotti, Angelo, Mannina, Donato, Cafro, Anna Maria, Cangialosi, Clotilde, Vincelli, Iolanda Donatella, Lombardo, Alessandra, Larocca, Alessandra, Boccadoro, Mario, D'Agostino, Mattia

“…Background. Before the recent introduction of daratumumab (Dara) in the frontline setting, lenalidomide-dexamethasone (Rd) has represented a standard of care…”
Get full text

Initial Results from a Phase 1 Dose-Escalation Study of WVT078, a BCMA×CD3 Bispecific Antibody, in Combination with WHG626, a Gamma-Secretase (GS) Inhibitor, in Patients with Relapsed and/or Refractory Multiple Myeloma by Schjesvold, Fredrik, Spencer, Andrew, Cohen, Yael C., Ocio, Enrique M, López-Pardo, Jordi, Cafro, Anna Maria, Callander, Natalie S., Kaufman, Jonathan L., Mohan, Meera, Wermke, Martin, Doki, Noriko, Kan, Rebecca, Kulec, Karolina, Trabucco, Gina, Ye, Stan, Sechaud, Romain, Quadt, Cornelia, Chawla, Raghav, Raab, Marc S.

“…Introduction: WVT078, a potent anti-B-cell maturation antigen (BCMA)×anti-CD3 bispecific antibody (BsAb), is being investigated as a single-agent and in…”
Get full text

Salvage Autologous Stem Cell Transplant for the Treatment of First Relapse Multiple Myeloma: Evidence of Its Clinical Role from a Multicenter Italian Study by Mangiacavalli, Silvia, Derudas, Daniele, Belotti, Angelo, Zamagni, Elena, Paris, Laura, Pavone, Vincenzo, Mina, Roberto, Di Renzo, Nicola, Fazio, Francesca, Tarantini, Giuseppe, Pezzatti, Sara, Palumbo, Gaetano, Marcatti, Magda, Vincelli, Jolanda Donatella, Cafro, Anna Maria, Falcone, Antonietta Pia, Zambello, Renato, Conticello, Concetta, Mazza, Rita, Di Raimondo, Francesco, Pompa, Alessandra, Martino, Enrica Antonia, Morabito, Fortunato, Stefanoni, Paola, Barila, Gregorio, Farina, Francesca, Cartia, Claudio Salvatore, Casson, Andrea, Ferretti, Virginia, Fresi, Eleonora, Arcaini, Luca, Petrucci, Maria Teresa, Gentile, Massimo

“…Background: Salvage autologous stem cell transplant (sASCT) has been indicated as possible therapeutic option at first (1 st) relapse, alternative to…”
Get full text

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse by Montefusco, Vittorio, Corso, Alessandro, Galli, Monica, Ardoino, Ilaria, Pezzatti, Sara, Carniti, Cristina, Patriarca, Francesca, Gherlinzoni, Filippo, Zambello, Renato, Sammassimo, Simona, Marcatti, Magda, Nozza, Andrea, Crippa, Claudia, Cafro, Anna Maria, Baldini, Luca, Corradini, Paolo

“…Summary Bortezomib‐ and lenalidomide‐containing regimens are well‐established therapies in multiple myeloma (MM). However, despite their extensive use,…”
Get full text

Dedalo: Phase II Study of Daratumumab Plus Pomalidomide and Dexamethasone (DPd) in Patients with Relapsed/Refractory Multiple Myeloma and 17p Deletion by Montefusco, Vittorio, Cafro, Anna Maria, Margiotta Casaluci, Gloria, Patriarca, Francesca, Mina, Roberto, D'Agostino, Mattia, Capra, Andrea, Priola, Claudia, Dalla Palma, Anna Benedetta, Rizzi, Rita, Genua, Angelo, Petrucci, Maria Teresa, Paris, Laura, Belotti, Angelo, Cavo, Michele, Conticello, Concetta, Carlo-Stella, Carmelo, Boccadoro, Mario

Get full text

Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody by Raab, Marc S., Cohen, Yael C., Schjesvold, Fredrik, Aardalen, Kimberly, Oka, Adwait, Spencer, Andrew, Wermke, Martin, Souza, Anita D., Kaufman, Jonathan L., Cafro, Anna Maria, Ocio, Enrique M., Doki, Noriko, Henson, Kristin, Trabucco, Gina, Carrion, Ana, Bender, Florent C., Juif, Pierre-Eric, Fessehatsion, Adonai, Fan, Liqiong, Stonehouse, Jeffrey P., Blankenship, John W., Granda, Brian, De Vita, Serena, Lu, Haihui

“…B-cell maturation antigen (BCMA) is an ideal target in multiple myeloma (MM) due to highly specific expression in malignant plasma cells. BCMA-directed…”
Get full text

Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients by Zappaterra, Arianna, Civettini, Ivan, Cafro, Anna Maria, Pezzetti, Laura, Pierini, Silvia, Anghilieri, Michela, Bellio, Laura, Bertazzoni, Paola, Grillo, Giovanni, Minga, Periana, Pioltelli, Maria L, Ravano, Emanuele, Sassone, Marianna, Viganò, Clara V, Volpato, Elisabetta B, Gambacorti-Passerini, Carlo, Rossini, Silvano, Cairoli, Roberto, Crocchiolo, Roberto

“…Induction with daratumumab-based regimens followed by autologous stem cell transplantation is the current standard for newly diagnosed multiple myeloma (NDMM)…”
Get full text